<DOC>
<DOCNO>EP-0646374</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Double-coated oxcarbazepine containing tablets
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K920	A61K3155	A61K930	A61K3155	A61P2504	A61P2500	A61K928	A61K928	A61K924	A61K936	A61K924	A61K920	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61P	A61P	A61K	A61K	A61K	A61K	A61K	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K9	A61K31	A61K9	A61K31	A61P25	A61P25	A61K9	A61K9	A61K9	A61K9	A61K9	A61K9	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to colour-stable tablets for the known active ingredient oxcarbazepine which are provided with a hydrophilic, permeable inner coating containing white colour pigments and with a hydrophilic, permeable outer coating containing white colour pigments combined with iron(II) oxide colour pigments.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
CIBA GEIGY AG
</APPLICANT-NAME>
<APPLICANT-NAME>
NOVARTIS AG
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BOURQUIN JACQUES
</INVENTOR-NAME>
<INVENTOR-NAME>
BOURQUIN, JACQUES
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
A double-coated tablet for the active ingredient 10,11-dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide,

which comprises

a) a tablet core comprising a therapeutically effective dose of 10,11-dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide;
b) a hydrophilic, permeable inner coating comprising white pigments and, if desired, further
excipients, and
c) a hydrophilic, permeable outer coating comprising white pigments combined with iron(II)
oxide pigments and, if desired, further excipients.
A double-coated tablet according to claim 1, which comprises

a) a tablet core comprising a dosage unit of the active ingredient 10,11-dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide;
b) a hydrophilic, permeable inner coating consisting of hydroxypropylmethylcellulose and
polyethylene glycol 8000 comprising titanium dioxide pigments, and
c) a hydrophilic, permeable outer coating consisting of hydroxypropylmethylcellulose and
polyethylene glycol 8000 comprising titanium dioxide pigments combined with iron(II) oxide

pigments.
A process for the preparation of a double-coated tablet for the active ingredient 10,11-dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide

which process comprises

a) compressing the active ingredient, with the admixture of conventional excipients and
using conventional tabletting methods, to form a tablet core and providing that core successively

with
b) a hydrophilic, permeable inner coating comprising white pigments and
c) a hydrophilic, permeable outer coating comprising white pigments combined with iron(II)
oxide pigments.
</CLAIMS>
</TEXT>
</DOC>
